228 related articles for article (PubMed ID: 16822381)
1. The ocular manifestations of atopic dermatitis and rosacea.
Eiseman AS
Curr Allergy Asthma Rep; 2006 Jul; 6(4):292-8. PubMed ID: 16822381
[TBL] [Abstract][Full Text] [Related]
2. Atopic dermatitis and keratoconjunctivitis.
Bielory B; Bielory L
Immunol Allergy Clin North Am; 2010 Aug; 30(3):323-36. PubMed ID: 20670816
[TBL] [Abstract][Full Text] [Related]
3. Childhood rosacea and related disorders.
Noguera-Morel L; Hernández-Martín A; Torrelo A
Clin Exp Dermatol; 2021 Apr; 46(3):430-437. PubMed ID: 33217048
[TBL] [Abstract][Full Text] [Related]
4. Rosacea and atopic dermatitis. Two common oculocutaneous disorders.
Barankin B; Guenther L
Can Fam Physician; 2002 Apr; 48():721-4. PubMed ID: 12046367
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory and papulosquamous disorders of the skin and eye.
Donshik PC; Hoss DM; Ehlers WH
Dermatol Clin; 1992 Jul; 10(3):533-47. PubMed ID: 1535574
[TBL] [Abstract][Full Text] [Related]
6. Anterior segment inflammation and skin disease.
Foulks GN
Int Ophthalmol Clin; 1983; 23(1):81-95. PubMed ID: 6219073
[No Abstract] [Full Text] [Related]
7. Dermatologic therapy in pregnancy.
Tyler KH
Clin Obstet Gynecol; 2015 Mar; 58(1):112-8. PubMed ID: 25517754
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement.
Mooney E; Rademaker M; Dailey R; Daniel BS; Drummond C; Fischer G; Foster R; Grills C; Halbert A; Hill S; King E; Leins E; Morgan V; Phillips RJ; Relic J; Rodrigues M; Scardamaglia L; Smith S; Su J; Wargon O; Orchard D
Australas J Dermatol; 2015 Nov; 56(4):241-51. PubMed ID: 25752907
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups.
Smith SD; Hong E; Fearns S; Blaszczynski A; Fischer G
Australas J Dermatol; 2010 Aug; 51(3):168-74. PubMed ID: 20695854
[TBL] [Abstract][Full Text] [Related]
10. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment.
Ljubojeviae S; Basta-Juzbasiae A; Lipozenèiae J
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):121-6. PubMed ID: 12046812
[TBL] [Abstract][Full Text] [Related]
11. Moisturizers for the treatment of inflammatory skin conditions.
Lynde C
J Drugs Dermatol; 2008 Nov; 7(11):1038-43. PubMed ID: 19110734
[TBL] [Abstract][Full Text] [Related]
12. [Atopic dermatitis].
Gerner T; Skov L; Thyssen JP
Ugeskr Laeger; 2018 Jan; 180(4):. PubMed ID: 29393034
[TBL] [Abstract][Full Text] [Related]
13. Ocular Co-Morbidities of Atopic Dermatitis. Part II: Ocular Disease Secondary to Treatments.
Beck KM; Seitzman GD; Yang EJ; Sanchez IM; Liao W
Am J Clin Dermatol; 2019 Dec; 20(6):807-815. PubMed ID: 31352589
[TBL] [Abstract][Full Text] [Related]
14. [Rosacea as a multisystemic disease].
Djaković Z; Milenković S; Pesko P; Djukić N
Srp Arh Celok Lek; 2003; 131(11-12):474-8. PubMed ID: 15114791
[TBL] [Abstract][Full Text] [Related]
15. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis.
Bernard LA; Cunningham BB; Al-Suwaidan S; Friedlander SF; Eichenfield LF
Arch Dermatol; 2003 Feb; 139(2):229-31. PubMed ID: 12588240
[No Abstract] [Full Text] [Related]
16. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
17. New and developing therapies for atopic dermatitis.
Hajar T; Gontijo JRV; Hanifin JM
An Bras Dermatol; 2018; 93(1):104-107. PubMed ID: 29641707
[TBL] [Abstract][Full Text] [Related]
18. Both pimecrolimus and corticosteroids deplete plasmacytoid dendritic cells in patients with atopic dermatitis.
Hoetzenecker W; Meindl S; Stuetz A; Stingl G; Elbe-Bürger A
J Invest Dermatol; 2006 Sep; 126(9):2141-4. PubMed ID: 16691192
[No Abstract] [Full Text] [Related]
19. Prescriptions for atopic dermatitis: oral corticosteroids remain commonplace.
Alexander T; Maxim E; Cardwell LA; Chawla A; Feldman SR
J Dermatolog Treat; 2018 May; 29(3):238-240. PubMed ID: 28789575
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial.
Sigurgeirsson B; Boznanski A; Todd G; Vertruyen A; Schuttelaar ML; Zhu X; Schauer U; Qaqundah P; Poulin Y; Kristjansson S; von Berg A; Nieto A; Boguniewicz M; Paller AS; Dakovic R; Ring J; Luger T
Pediatrics; 2015 Apr; 135(4):597-606. PubMed ID: 25802354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
